NEO Competitors & Alternatives
Compare NeoGenomics Inc with similar stocks in the same industry
Diagnostics & Research
NEO
Main Stock$17.32
Tradestie Score
43
Market Cap
$1.13B
Revenue Growth
0.1%
Analyst Upside
+13.9%
Top Competitors
35 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$85.27
|
$3.26B | - | 36 | Compare |
|
VCYT
Veracyte, Inc.
|
$40.87
|
$2.85B | 31.4 | 52 | Compare |
|
GRAL
GRAIL, Inc. Common Stock
|
$76.23
|
$2.24B | - | 49 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$24.20
|
$2.22B | - | 55 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$127.22
|
$1.77B | - | 46 | Compare |
|
NVCR
NovoCure Limited Ordinary Shares
|
$15.51
|
$1.56B | - | 47 | Compare |
|
NEOG
Neogen Corp
|
$11.78
|
$1.26B | - | 46 | Compare |
|
OPK
Opko Health Inc.
|
$1.57
|
$1.23B | - | 43 | Compare |
|
CDNA
CareDx, Inc.
|
$50.26
|
$798.40M | 24.0 | 37 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$20.45
|
$719.31M | - | 48 | Compare |
More NEO Analysis
Data updated: Sep 13, 2026 | Industry: Diagnostics & Research (SIC 8734)
35 stocks in this industry